RedHill Biopharma (RDHL) Other Gross PP&E Adjustments: 2011-2025
Historic Other Gross PP&E Adjustments for RedHill Biopharma (RDHL) over the last 5 years, with Jun 2025 value amounting to -$163,000.
- RedHill Biopharma's Other Gross PP&E Adjustments rose 65.25% to -$163,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.9 million, marking a year-over-year increase of 79.96%. This contributed to the annual value of -$302,000 for FY2024, which is 69.46% up from last year.
- As of Q2 2025, RedHill Biopharma's Other Gross PP&E Adjustments stood at -$163,000, which was up 46.03% from -$302,000 recorded in Q4 2024.
- In the past 5 years, RedHill Biopharma's Other Gross PP&E Adjustments registered a high of -$163,000 during Q2 2025, and its lowest value of -$7.7 million during Q1 2022.
- In the last 3 years, RedHill Biopharma's Other Gross PP&E Adjustments had a median value of -$729,000 in 2023 and averaged -$1.7 million.
- In the last 5 years, RedHill Biopharma's Other Gross PP&E Adjustments crashed by 83.29% in 2022 and then skyrocketed by 85.22% in 2023.
- Over the past 5 years, RedHill Biopharma's Other Gross PP&E Adjustments (Quarterly) stood at -$3.7 million in 2021, then slumped by 83.29% to -$6.7 million in 2022, then surged by 85.22% to -$989,000 in 2023, then skyrocketed by 69.46% to -$302,000 in 2024, then spiked by 65.25% to -$163,000 in 2025.
- Its last three reported values are -$163,000 in Q2 2025, -$302,000 for Q4 2024, and -$469,000 during Q2 2024.